$140M
The financing values the biotechnology company at $800m and will support its in vivo cell therapy pipeline.
BR
Basecamp Research
A biotechnology company developing biological foundation models and cell therapies.
$202MTotal raised
Basecamp Research builds biological foundation models on proprietary genetic datasets to engineer in vivo cell therapies.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Shareholders' funds
Members only
Current assets
Members only
Employees
Members only
Cash, assets and headcount from Basecamp Research's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
OV
Oliver Vince
Oliver brings engineering and research experience from the University of Oxford and Basecamp Research, where he serves as co-founder.
LinkedIn
Glen Gowers
Chief Executive
Glen is co-founder and CEO of Basecamp Research, following a PhD in synthetic biology at Imperial College London.
LinkedInInvestors
- $140M
- £45.9M
- £16.1M
Funding history
£45.9M
Singular led the Series B round, which will help fund data collection and foundational model development.
£16.1M
Systemiq Ventures led the Series A round to support team expansion and product development.